Amneal intros FocinvezFocinvez 150 mg/50 mL single dose vial is an anti-nausea agent for emetogenic chemotherapy. Arunesh Verma joins Fresenius Kabi USA as presidentVerma succeeds John Ducker who will retire after 35 years with the company. Fresenius debuts subcutaneous formulation of biosimilar Tyenne Tyenne is an FDA-approved tocilizumab biosimilar that is available in both intravenous and subcutaneous formulations. Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz This expanded partnership solidifies Just – Evotec Biologics’ commitment to providing long-term commercial supply of biosimilars to Sandoz. Yaral Pharma becomes exclusive supplier of authorized generic levothyroxine sodium capsules Levothyroxine Sodium Capsules are used to treat hypothyroidism. FDA gives Lupin tentative approval for generic Trijardy Trijardy contains three diabetes medications: empagliflozin, linagliptin and metformin hydrochloride. FDA approves Jiangsu Hengrui’s generic Exparel The FDA has approved bupivacaine liposome, which is a generic of Pacira BioScience's Exparel. ANI receives FDA nod for generic EC-Naprosyn Naproxen delayed-release tablets are a type of nonsteroidal anti-inflammatory drug. American Regent releases sodium phosphates injection Sodium phosphates injection is indicated to prevent hypophosphatemia in patients with restricted or no oral intake. DOJ clears Viatris’ Mylan of generic drug antitrust investigation DOJ does not expect to take any further actions against Viatris in connection with a civil investigative demand related to the pricing and sales of generic drugs. First Previous 26 27 28 29 30 Next Last
